Continuous Glucose Monitoring Devices Market Demonstrates Long-Term Growth Potential At 16.6% CAGR

The continuous glucose monitoring devices market is on the verge of significant expansion, driven by technological advances and changing healthcare needs. With innovations aimed at improving diabetes management and patient convenience, this industry is set to experience notable growth over the coming years. Here's an in-depth look at the market's size, key players, trends, and segment breakdowns shaping its future.

Steady Growth Projections in the Continuous Glucose Monitoring Devices Market
The market for continuous glucose monitoring devices is projected to grow impressively, reaching a value of $21.13 billion by 2030. This expansion corresponds to a robust compound annual growth rate (CAGR) of 16.6%. Several factors contribute to this upward trajectory, including the rising demand for interoperable diabetes devices and increased investment in AI-driven glucose prediction technologies. Additionally, the expansion of remote diabetes care models and a focus on data-driven treatment optimization are fueling market advancement. The adoption of next-generation sensor materials also plays a crucial role in supporting sustained growth. Noteworthy trends expected to influence the market include a surge in non-invasive CGM technologies, greater use of cloud-connected glucose monitoring systems, enhancements in predictive glucose analytics, longer-wearing sensor solutions, and an emphasis on designs that improve ease of use for patients.

Download a free sample of the continuous glucose monitoring devices market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20733&type=smp&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Prominent Players Leading the Continuous Glucose Monitoring Devices Sector
The continuous glucose monitoring devices market features several key players who dominate the industry landscape. These include Johnson & Johnson, F. Hoffmann-La Roche AG, Sanofi S.A., Abbott Laboratories, Medtronic Public Limited Company, Novo Nordisk A/S, Becton dic*kinson and Company, A. Menarini Diagnostics S.r.l., Dexcom Inc., Bionime Corporation, Insulet Corporation, Ascensia Diabetes Care Holdings AG, Tandem Diabetes Care Inc., i-Sens Inc., Senseonics Holdings Inc., Medtrum Technologies Inc., Biolinq Inc., GlySens Incorporated, Glucotrack Inc., and Nemaura Medical Inc.

Abbott Laboratories made a significant move in September 2023 by acquiring Bigfoot Biomedical Inc., a US-based medical technology company specializing in smart insulin management systems compatible with continuous glucose monitoring devices. This acquisition aims to enhance Abbott's diabetes care offerings by integrating Bigfoot's technology with its existing Freestyle Libre CGM systems.

View the full continuous glucose monitoring devices market report:
https://www.thebusinessresearchcompany.com/report/continuous-glucose-monitoring-devices-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Jul_PR

Emerging Innovations Shaping the Continuous Glucose Monitoring Devices Industry
Innovation remains at the forefront of this market, with major companies focusing on enhancing accessibility and ease of use through new technologies like over-the-counter continuous glucose monitors. These devices allow individuals to monitor their blood glucose levels continuously without requiring a prescription, broadening access to diabetes management tools.

For example, Abbott Laboratories introduced the Lingo continuous glucose monitoring system in September 2024. This device provides real-time glucose data, enabling users to track their blood sugar levels throughout the day with instant feedback. It features a sleek, user-friendly design and integrates with mobile applications to help users monitor trends and receive alerts, making diabetes management more convenient and effective.

Segment Overview Highlighting the Continuous Glucose Monitoring Devices Market
This market is segmented into various categories that help define its scope and target applications:
1) Component types including transmitters, sensors, and receivers
2) Connectivity options such as Bluetooth and 4G
3) Demographic groups encompassing child and adult populations
4) Applications involving gestational diabetes, type-2 diabetes, and type-1 diabetes
5) End-use environments like hospitals, homecare settings, and other users

Further subsegments include transmitter types such as Bluetooth-enabled transmitters, wireless transmitters, and integrated transmitter-receiver systems. Sensors are classified into enzyme-based, electrochemical, and non-invasive types. Receivers cover mobile device integration (smartphone receivers), standalone receivers, and those offering cloud-based data synchronization.

This detailed segmentation helps in understanding the diverse needs and technological variations within the continuous glucose monitoring devices market, supporting targeted innovations and effective healthcare delivery.

Our latest 2026 market reports provide expanded strategic and visual intelligence with market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, together with updated graphics and tables.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.